25 results on '"Guglielmelli, P."'
Search Results
2. ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
3. Inherited polygenic effects on common hematological traits influence clonal selection on JAK2V617F and the development of myeloproliferative neoplasms
4. Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes
5. Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting
6. Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib
7. Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study
8. Restoring of Interhemispheric Symmetry in Patients With Stroke Following Bilateral or Unilateral Robot-Assisted Upper-Limb Rehabilitation: A Pilot Randomized Controlled Trial
9. One thousand patients with essential thrombocythemia: the Florence-CRIMM experience
10. Intrinsic Superchirality in Planar Plasmonic Metasurfaces.
11. Inherited polygenic effects on common hematological traits influence clonal selection on JAK2V617Fand the development of myeloproliferative neoplasms
12. Book Review: VIRUS POPULISTA? Narrative della crisi pandemica in Italia, Francia e Spagna
13. A safety evaluation of ruxolitinib for the treatment of polycythemia vera
14. Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis
15. CALRmutation burden in essential thrombocythemia and disease outcome
16. Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib.
17. Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting.
18. Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia.
19. Targeting exhausted cytotoxic T cells through CTLA-4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts.
20. Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study.
21. CALR mutation burden in essential thrombocythemia and disease outcome.
22. Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion.
23. One thousand patients with essential thrombocythemia: the Florence-CRIMM experience.
24. Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia.
25. The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.